The Temozolomide–Doxorubicin paradox in Glioblastoma in vitro–in silico preclinical drug-screening.

Autor: Oraiopoulou, Mariam-Eleni1,2 (AUTHOR), Tzamali, Eleftheria1 (AUTHOR), Psycharakis, Stylianos E.3,4 (AUTHOR), Tzedakis, Georgios1 (AUTHOR), Makatounakis, Takis5 (AUTHOR), Manolitsi, Katina6 (AUTHOR), Drakos, Elias4,6 (AUTHOR), Vakis, Antonis F.4,6 (AUTHOR), Zacharakis, Giannis3 (AUTHOR), Papamatheakis, Joseph5,7 (AUTHOR), Sakkalis, Vangelis1 (AUTHOR) sakkalis@ics.forth.gr
Zdroj: Scientific Reports. 2/15/2024, Vol. 14 Issue 1, p1-12. 12p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje